References

Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the global burden of disease study 2023

10.1016/s0140-6736(25)01853-7 · 2025 · External reference

Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021

10.3389/fpubh.2025.1542329 · 2025 · External reference

KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease

10.1016/j.kint.2023.10.018 · 2024 · External reference

Chronic kidney disease: global dimension and perspectives

10.1016/s0140-6736(13)60687-x · 2013 · External reference

Emerging biomarkers and advanced diagnostics in chronic kidney disease: early detection through multi-omics and AI

10.3390/diagnostics15101225 · 2025 · External reference

Recent advances in urinary peptide and proteomic biomarkers in chronic kidney disease: a systematic review

10.3390/ijms24119156 · 2023 · External reference

Novel biomarkers for prognosticating diabetic kidney disease progression

10.1007/s11255-022-03354-7 · 2023 · External reference

A novel reproductive peptide, phoenixin

10.1111/j.1365-2826.2012.02381.x · 2013 · External reference

Phoenixin: more than reproductive peptide

10.3390/ijms21218378 · 2020 · External reference

Regulation and physiological functions of phoenixin

10.3389/fmolb.2022.956500 · 2022 · External reference

Current state of phoenixin: the implications of the pleiotropic peptide in stress and its potential as a therapeutic target

10.3389/fphar.2023.1076800 · 2023 · External reference

Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotection

10.1007/s00018-017-2661-3 · 2018 · External reference

Protective effects of phoenixin-14 administration against renal ischemia/reperfusion injury in rats

10.1002/jbt.70200 · 2025 · External reference

New creatinine- and cystatin C-based equations to estimate GFR without race

10.1056/nejmoa2102953 · 2021 · External reference

Investigation of serum phoenixin levels in patients with hypertension

10.1590/1806-9282.20220153 · 2022 · External reference

The levels of phoenixin-14 and phoenixin-20 in patients with type 2 diabetes mellitus

10.2174/0118715303267256231210060250 · 2024 · External reference

An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure

10.1080/14737159.2023.2216386 · 2023 · External reference

Precision medicine in erythropoietin deficiency and treatment resistance: a novel approach to management of anemia in chronic kidney disease

10.3390/cimb45080413 · 2023 · External reference

Role of uremic toxins, oxidative stress, and renal fibrosis in chronic kidney disease

10.3390/antiox13060687 · 2024 · External reference

Protein-bound uremic toxins impaired mitochondrial dynamics and functions

10.18632/oncotarget.20773 · 2017 · External reference

A systematic scoping review of the multifaceted role of phoenixin in metabolism

10.3389/fendo.2024.1406531 · 2024 · External reference

Kinetics of atrial and brain natriuretic peptides during hemodialysis are regulated in association with different cardiac functional changes

10.1007/s00380-021-02011-w · 2022 · External reference

A novel mathematical model of protein-bound uremic toxin kinetics during hemodialysis

10.1038/s41598-017-10981-z · 2017 · External reference

Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study

10.1007/s40620-017-0393-y · 2018 · External reference

Chronic kidney disease-mineral and bone disorder: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference

10.1016/j.kint.2024.11.013 · 2025 · External reference

Chronic kidney disease

2024 · External reference

10.1002/9781118548387

10.1002/9781118548387 · 2013 · External reference

Relationship between serum levels of LOX-1, hs-cTnT, NGAL, and renal function, and their diagnostic value in patients with chronic kidney disease: a retrospective study

10.1186/s12882-024-03875-6 · 2024 · External reference

Association of phoenixin-14 with body mass index categories and proteinuria in adults with type 2 diabetes

10.3390/medicina62040697 · 2026 · External reference

Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact

10.1093/clinchem/47.5.901 · 2001 · External reference